NEWS
View news from our Featured Companies.
Scientific Industries to Host Fiscal Year 2024 Financial Results Investor Call on April 1, 2025
Investor Call to be held at 11:00 AM Eastern TimeBOHEMIA, N.Y., April 01, 2025 -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it filed the Form 10K and issued a...
InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer
The Company Reaffirms Full Year 2025 Guidance: Revenue Growth of 8-10% and Adjusted EBITDA (non-GAAP) margin greater than 18.8% ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care...
ARIANNE PHOSPHATE MAKES ANNUAL INTEREST PAYMENT ON ITS CREDIT FACILITY
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) SAGUENAY, QC, March 31, 2025 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQX: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul...
Scientific Industries Reports Financial Results for Fiscal Year Ended December 31, 2024 and Launches DOTS MPS for Cell Culture Biopharma Market
BIOPROCESSING OPERATIONS: 24% REVENUE GROWTH DRIVEN BY NEWLY LAUNCHED PRODUCTS OPERATIONAL EFFICIENCIES CUT TOTAL NET LOSSES BY 29% LAUNCHED NEW STATE OF THE ART VIVID WORKSTATION Investor Call to be held Tuesday, April 1st at 11:00 a.m. Eastern Time BOHEMIA, N.Y.,...
LiqTech International to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025
BALLERUP, Denmark, March 31, 2025 -- LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration company that manufactures and markets highly specialized filtration products and systems, today announced that it will participate in a webcasted fireside chat at...
SenesTech to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025
PHOENIX, March 31, 2025 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in fertility control solutions for managing rodent populations, today announced that it will participate in a webcast fireside chat at the Lytham Partners 2025...
Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights
- Favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year for once daily brilaroxazine in open-label extension (OLE) trial - - Registrational Phase 3 RECOVER-2 trial initiation for brilaroxazine expected mid-2025 - - Full data set from...
Jewett-Cameron to Participate in Upcoming Investor Conferences
NORTH PLAINS, Ore., March 31, 2025 -- Jewett-Cameron Trading Company Ltd. (NASDAQ: JCTC), a company committed to innovative products that enrich outdoor spaces, today announced that in its continued efforts to increase investor awareness of the Company, which have...
Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress
CUPERTINO, Calif., March 30, 2025 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic...
LiqTech International Announces Financial Results for Fourth Quarter and Full Year 2024
BALLERUP, Denmark, March 28, 2025 -- LiqTech International, Inc. (Nasdaq: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results for the fourth quarter and fiscal...
Precision Optics to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025
GARDNER, Mass., March 27, 2025 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it will participate in a webcasted fireside...
Zoomd Technologies Reports Fourth Quarter and Fiscal 2024 Financial Results
Conference call will be held on March 26, 2025 at 11AM ET TORONTO, March 25, 2025 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech)...
A Major Step Forward in Circularity: Aquafil Breaks New Ground in Textile Recycling by Chemically Separating Elastic Fibers from Nylon
Aquafil's engineers and R&D team have found a way to separate what was once inseparable TRENTO, Italy - What was once considered impossible is now within reach. After more than ten years of relentless research and innovation, Aquafil has unveiled a breakthrough in...
LiqTech to Discuss Fourth Quarter and Fiscal Year 2024 Results on Friday, March 28, 2025
Management to Host Conference Call on Friday, March 28, 2025, at 9:00 a.m. ET BALLERUP, Denmark, March 20, 2025 -- LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration company that manufactures and markets highly specialized filtration products and...
Zoomd to Report Fourth Quarter and Full Year 2024 Financial Results
Conference call to be conducted on March 26, 2025, at 11 a.m. ET TORONTO, March 20, 2025 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech)...
Modular Medical Announces $12 Million Private Placement
SAN DIEGO, CA / ACCESS Newswire / March 20, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of "almost-pumpers" with...
Precision Optics Appoints Joseph P. Pellegrino, Jr. to Board of Directors
GARDNER, Mass., March 20, 2025 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, is pleased to announce the appointment of Joseph P. "JJ"...
NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues
Conference call will be held today, Thursday, March 20 at 9:00 am ETCARMEL, Ind., March 20, 2025 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating...
Mogo Reports Results for Q4 & FY 2024
Company reports Net Income of $10.4 million for Q4 2024 Total Revenue Increases 5% in Q4 and totaled $71.2 million for FY 2024 Wealth Revenue Increases 19% in Q4 and totaled $10.7 million for FY 2024 Payments Revenue Increases 27% in Q4 and totaled $8.6 million for FY...
Niagen Bioscience Secures U.S. Patent for the Composition of Matter for Nicotinamide Riboside (NR) Salt Forms
Exclusively licensed from Queen's University Belfast (QUB), this composition of matter patent, one of the most robust forms of intellectual property protection, grants Niagen Bioscience exclusive rights to various salt forms of NR and derivatives LOS ANGELES - Niagen...
Mogo to Announce Q4 2024 Financial Results March 20, 2025
VANCOUVER, British Columbia - Mogo Inc. (TSX:MOGO) (NASDAQ:MOGO) ("Mogo" or the "Company"), a digital wealth and payments business, today announced it will hold a conference call and webcast to discuss its Q4 & full-year 2024 financial results on Thursday, March...
Zoomd to Participate at Planet MicroCap in Las Vegas
TORONTO, March 19, 2025 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), a leading marketing technology (MarTech) platform specializing in user acquisition and engagement, is...
ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of Uncovering the Potential of NAD+ With Precision Science
The rebrand celebrates the company's clinically proven flagship patented nicotinamide riboside (NR) ingredient, Niagen, the most well-researched, efficient, high-quality, and legal NAD+ booster available LOS ANGELES - Niagen Bioscience, Inc. (Nasdaq: NAGE) (formerly...
Greenfire Resources Reports Year End 2024 Reserves, Fourth Quarter and Full Year 2024 Results, and Provides an Operational Update
Readers are advised to review the "Presentation of Reserves and Other Oil and Gas Information" and "Non-GAAP and Other Financial Measures" at the conclusion of this news release for information regarding the presentation of the reserves information, as well as certain...
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering
GAITHERSBURG, Md., March 13, 2025 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma"), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT),...